Evolutionary consequences of DNA methylation on the GC content in vertebrate genomes

Aberrant phase separation of transcription factors in human developmental disorders

DBX2 REGULATION IN LIMBS SUGGESTS INTER-TAD SHARING OF ENHANCERS [HiC reanalysis]

Dimeric G-quadruplex motifs-induced NFRs determine strong replication origins in vertebrates

Affymetrix SNP array data for beak deformity and normal Beijing-You Chickens

Genomic Analysis Reveals Pleiotropic Alleles at EDN3 and BMP7 Involved in Chicken Comb Color and Egg Production

Affymetrix SNP array data for chicken samples

Affymetrix SNP array data for Dwarf and Rhode Island Red chicken samples

Genome-wide association analysis and genome resequencing reveal a genomic duplication possibly concerning a novel chicken comb morphology

Affymetrix SNP array data for chicken responses to glycoconjugate vaccination against Campylobacter jejuni

Interferon regulatory factor 5 expression levels regulate murine lupus in a type-I interferon-independent manner

Murine serum reactivity to common autoantigens in response to immunization with neutrophil extracellular traps

Specific post-translational histone mod. of neutrophil extracellular traps as immunogens & potential SLE Ab targets.

Histone protein and peptide reactivity within patients with systemic lupus erythematosus (SLE) from the ABCoN cohort

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training IgG 1:50]

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training IgM 1:50]

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training Total Ig 1:50]

Baseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training Total Ig 1:200]

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation IgG 1:50]

Baseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation IgM 1:50]